In recent years there is a huge leap of pharma industry towards rare diseases and orphan drug developments due to the great support from regulatory authorities such as faster approval timelines, supportive regulatory frameworks, financial incentives and many more. Currently, large pharmaceutical companies are extremely active in the orphan drugs market. Novartis, GSK, Roche, and […]

Read More →

A country with large pool of patients, highly skilled Investigators and supportive regulations to promote clinical research is a desired destination for any organisation to conduct Clinical Trials. India has a lot more to offer besides these advantages, enabling you to enjoy timely completion of trials and cost benefits. (It is estimated that India offers 35 […]

Read More →